4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0000899243-22-003469
Options or other derivatives
- Chief Legal Officer acquired 202,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kearns Evan Chief Legal Officer | 2022-01-25 | Grant or award · Stock Option (Right to Buy) | +202,250 | $4.94 | $999,762 | 202,250 | D |
Loading xslF345X03/doc4.xml…